The hospital average length of stay for malignant neoplasm of the uterus in France has shown a consistent downward trend from 2024 to 2028. In 2023, the average length of stay stood at 5.2 days. From 2024 onwards, a forecasted gradual decrease is observed, from 5 days in 2024 to 4.5 days in 2028. The year-on-year percentage decrease is approximately consistent, ranging around 2-5%, indicating a steady improvement in efficiency and healthcare practices. The compound annual growth rate (CAGR) over this period would reflect an average annual reduction in the length of stay of about 3.1%.
Future trends to watch for include the impact of advancements in medical technology and treatment protocols, which may lead to even shorter hospital stays. Moreover, the role of outpatient services and telemedicine could further influence these trends, potentially improving patient outcomes while reducing time spent in hospitals.
